Oak Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,602
Closed -$257K 108
2025
Q2
$257K Sell
10,602
-1,650
-13% -$38.5K 0.09% 94
2025
Q1
$310K Sell
12,252
-175
-1% -$4.58K 0.11% 87
2024
Q4
$330K Sell
12,427
-5,528
-31% -$150K 0.12% 85
2024
Q3
$520K Sell
17,955
-5,860
-25% -$171K 0.18% 72
2024
Q2
$666K Sell
23,815
-400
-2% -$11K 0.24% 67
2024
Q1
$672K Buy
24,215
+6,809
+39% +$189K 0.25% 67
2023
Q4
$501K Sell
17,406
-3,570
-17% -$108K 0.2% 69
2023
Q3
$696K Buy
20,976
+4,800
+30% +$170K 0.3% 61
2023
Q2
$593K Hold
16,176
0.25% 66
2023
Q1
$660K Sell
16,176
-343
-2% -$14.8K 0.28% 63
2022
Q4
$846K Hold
16,519
0.38% 57
2022
Q3
$723K Buy
+16,519
New +$803K 0.35% 59
2022
Q2
Sell
-16,165
Closed -$837K 136
2022
Q1
$837K Hold
16,165
0.33% 59
2021
Q4
$955K Buy
16,165
+232
+1% +$11.5K 0.36% 58
2021
Q3
$658K Hold
15,933
0.27% 67
2021
Q2
$624K Buy
15,933
+57
+0.4% +$2.22K 0.26% 68
2021
Q1
$575K Buy
15,876
+1,530
+11% +$54.3K 0.31% 46
2020
Q4
$528K Buy
14,346
+754
+6% +$27.7K 0.26% 71
2020
Q3
$483K Buy
13,592
+314
+2% +$11K 0.26% 69
2020
Q2
$412K Buy
13,278
+853
+7% +$29K 0.24% 70
2020
Q1
$385K Buy
+12,425
New +$423K 0.28% 65
2018
Q2
Sell
-6,103
Closed -$205K 95
2018
Q1
$205K Sell
6,103
-780
-11% -$26.8K 0.16% 88
2017
Q4
$237K Buy
+6,883
New +$235K 0.18% 81

Other funds holding PFE

Oak Asset Management's PFE Position: Q3 2025 in Review

Oak Asset Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 10,602 shares — an estimated $257K sold.

Oak Asset Management first reported a position in PFE in Q4 2017 and held it in 23 quarters. The position peaked at $955K in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Oak Asset Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Oak Asset Management sold 10,602 Pfizer shares in Q3 2025, an estimated $257K.
  • Oak Asset Management first reported a position in Pfizer in Q4 2017 and held it in 23 quarters.
  • Oak Asset Management's Pfizer position peaked at $955K in Q4 2021.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Oak Asset Management's 13F filing for Q3 2025, filed 20 Oct 2025.